Welcome and Introduction - Dianne Webster (Chair), Director Newborn Metabolic Screening Programme, Auckland District Health Board |
Current state of play? An overview of NBS expansion around the world - Bridget Wilcken, Senior Staff Specialist, Centre for Clinical Genetics, Sydney Children’s Hospital |
Developing technologies in NBS – how can we seperate early vs late disease vs false-positives? - Veronica Wiley, Principal Scientist/ Director - NSW Newborn Screening Program |
What is available vs what is needed for long-term follow up of late onset patients (i.e. a gap analysis of current practices). - Drago Bratkovic, Head, Metabolic Unit - Women's and Children's Hospital, North Adelaide |
Q & A
